CLPT ClearPoint Neuro Inc.

$13.72▲ +1.78% Healthcare Other
After hours $13.72▲ +0.00% Sep 11, 7:48 PM ET
Volume 1.02M Avg Volume (10D) 556.2K
Key Metrics & Fundamentals
Market Cap
$418.52M
P/E Ratio
–
Div Yield
–%
52W Range
8.27 - 30.10
% vs 50 MA
-9.88%
% vs 200 MA
2.27%
RSI-14
40.2
MACD Histogram
-0.2000
Beta (1Y vs SPY)
1.71
Free Cash Flow
-$7.23M
Gross Rev
$10.88M
Gross Profit
$6.71M
EBITDA
-$8.59M
COGS
$4.17M
Operating Exp
$16.95M
Operating Income
-$10.24M
EBIT
-$10.24M
Pretax Income
-$11.38M
Net Income
-$11.34M
EPS (Diluted)
-0.38
Price & Volume History
Loading chart…
Recent News
ClearPoint Neuro (CLPT) Stock Sees Fair Value Cut As Analysts Factor In Heavier Investment
Simply Wall St. · Sep 4, 2026 12:14 PM
ClearPoint Neuro (CLPT) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 11, 2026 1:48 AM
ClearPoint Neuro, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 4, 2026 12:30 PM
ClearPoint Neuro (CLPT) Reports Q2 Earnings: What Key Metrics Have to Say
Zacks · Aug 3, 2026 11:00 PM
ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Misses Revenue Estimates
Zacks · Aug 3, 2026 10:45 PM
ClearPoint Neuro Q2 Earnings Call Highlights
MarketBeat · Aug 3, 2026 10:03 PM
ClearPoint Neuro Reports Second Quarter 2026 Results
ACCESS Newswire · Aug 3, 2026 8:05 PM
ClearPoint Neuro Congratulates Partner Aspen Neuroscience on FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Sasineprocel
ACCESS Newswire · Jul 31, 2026 8:05 PM
Earnings To Watch: ClearPoint Neuro Inc (CLPT) Q2 2026 -- GF Value Sees 28% Upside
GuruFocus.com · Jul 31, 2026 1:19 PM
Analysts Estimate Orthofix (OFIX) to Report a Decline in Earnings: What to Look Out for
Zacks · Jul 29, 2026 2:00 PM
Financial Overview - Income Statement Quarterly

See CLPT's money flow as a full page

Social Sentiment
Avg +0.80 · 1 posts
TradeDiscussionNews$300K CLPT YOLO
r/wallstreetbets · Oct 16, 2025
The author expresses extreme conviction ('one of my highest conviction plays') and refers to the company's technology driving QURE’s success.
very_positive +0.80
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙